CN
Company Introduction

HKND focuses on the global cutting-edge biotechnology field, through multi-level methods such as strategic investment, participation in operations, holding and steering, professional mergers and in-depth integration of high-quality assets in the global high-tech biological field.

HKND builds a global cutting-edge biotechnology industry ecological development platform with cutting-edge technology research and development capabilities, top innovation and creativity capabilities, and broad market development potential by linking, aggregating, and attracting core technology industry projects in the global life sciences.

HKND uses an innovative management system to provide all-round empowerment for ecological enterprises, to help and lead the efficient growth of ecological enterprises, to a more accessible capitalization path, and ultimately to maximize the ecological value of the entire industry chain.

  • Globalization
    HKND is headquartered in Singapore and Hong Kong, the company is based on the world, and explores the most cutting-edge, most valuable and potential biotechnology M&A investment opportunities in the world.
  • High-tech
    HKND masters the cutting-edge core technology in the field of global life sciences, recruits the world's top scientific and technological talents, and creates high-tech innovation professional technical barriers with top R&D strength.
  • Big capital
    HKND gives full play to its strong capital energy and endowment core, provides strong financial support for its multiple ecological enterprises with an output value of over ten billion, and uses big capital to escort the development of ecological industry.
Core Values
Focus-Focusing on the Global Cutting-edge Biotechnology Field
HKND is an integrated M&A holding platform company focused on the global cutting-edge biotechnology industry, based on the research and development of life science technology, with the goal of cutting-edge innovative drug research and development, driven by AI and advanced data science, and focusing on the global cutting-edge biotechnology industry, committed to building a global leading biotechnology industry ecological development platform, headquartered in Singapore and Hong Kong, and explores the most cutting-edge, most valuable and potential biotech M&A opportunities on a global scale.
Persistence - Providing Core Power for High-quality Development with Science and Technology
We insist on leading innovation with science and technology, pursue, explore and develop core science and technology in the field of biomedicine, and aim to solve the most challenging health problems through the world's top technologies. Science and technology is the core driving force for the high-quality development of HKND. We have invested a lot of funds in the field of science and technology research and development to support the enterprise's high-tech research and development; We have recruited the world's top scientific and technological talents, and 80% of our core team members devote themselves to scientific research, creating the company's top scientific research strength and innovative professional technical barriers.
Excellence -Mastering the Core Technology in the Global Biomedical Field
The subdivisions we focus on cover cutting-edge new drug creation, digital life, innovative precision medical devices, IVD and precision medicine, and other new medical technologies. At present, our ecological enterprise holds a global multi-omics digital life ecosystem, cutting-edge technology in the precision medical field of infection medicine, the most cutting-edge oncolytic bacterial immunotherapy technology in the field of tumor immunotherapy, and global biomedical fields such as AI+ new drug research and development. Important core technology, tempering excellent quality in the field of high-tech innovation research and development.
Co-progress - Comprehensive Empowerment to help Ecological Enterprises Develop
Relying on the profound scientific and technological precipitation and connotation and relying on the scientific research expert team from many fields such as computing science, synthetic biology and drug discovery, HKND is committed to building a holding investment and development platform with multi-dimensional endowment energy through all-round empowerment of capital, resources and talents, and deeply participating in the whole life cycle of the development of biotechnology enterprises, lay a professional and efficient capitalization path for ecological enterprises, operate and grow together with ecological enterprises, achieve win-win progress, and achieve long-term sustainable and high-quality growth.
Mission & Vision
Relying on its global leading cutting-edge biotechnology ecological industry development platform, HKND is committed to comprehensively and systematically solving the most challenging human health problems, taking this opportunity to deeply explore the nature of life activities and the law of development, relying on the power of science and technology to realize the three-dimensional perception, effective control, and even active transformation and management of life activities, making positive contributions to improving global health and benefiting human society.
Ecological Shareholders
In the process of moving forward, we have also reaped many reliable partners walking hand in hand. In the future, HKND will be committed to cooperating with other shareholders, investors and partners to accompany the whole life cycle of the development of ecological enterprises and achieve multi-directional benign, low-risk and value-added growth and development.
Manage the team
Ma WeihuaDirector

Executive Director of China Finance Society, former President of China Merchants Bank

Doctor of Economics, Southwestern University of Finance and Economics, Honorary Doctor of University of Southern California, Senior Economist

Current Chairman of One Foundation, Chairman of the Board of Shenzhen International Philanthropy Institute

President of Shenzhen Municipal Quality City Promotion Association, Vice President of China Entrepreneurs Association

China's most innovative banker representative, influential business leader, winner of the title of "China Outstanding Contribution Entrepreneur"

Wang JunCEO

Founder of iCarbonX; former CEO, Director, Dean of Research Institute of BGI Professor of University of Copenhagen, Visiting Professor of Hong Kong University and Hong Kong University of Science and Technology

Vice President of China Youth Science and Technology Workers Association, Vice President of Shenzhen Youth Federation, Vice President of Shenzhen Peking University Alumni Association

Bioinformatics and Genomics Scientist / 973 Chief Scientist / National Candidate for New Century Talent Project

  • Ma Weihua
    Director
  • Wang Jun
    CEO

Contact information

© 2020 Copyright, All Rights Reserved by HKND